Although the clinical inhibition of ABC transporters is disappointing and their prognostic value in breast cancer is conflicting, by overcoming the above obstacles, the modulation of ABC transporters may eventually represent a promising strategy to prevent the chemoresistance, progression and metastasis of breast cancers. The gene discussed is ABCG2; the disease is breast cancer.